Analysis: EU’s “Waiver” of Some Compulsory Licensing Requirements Wouldn’t Even Scratch the Surface of the COVID-19 Health Products’ Inequitable Access Crisis October 14, 2021
Factsheet: Contrary to Pharma Company Promises, COVID-19 Vaccine Producers Are Not on Track to Make Enough for Everyone July 30, 2021
Fact Sheet: We Must End Trade-Pact Obstructions Against Global Production of COVID-19 Vaccines & Treatments July 29, 2021
How Overreaching “Trade” Pact Rules Can Undermine Buy American and Other Domestic Preference Procurement Policies July 28, 2021
Don’t Buy Pharma’s Latest Distraction: A Temporary WTO IP Waiver for COVID Meds Would Not Hand “U.S. mRNA Technology” to China May 3, 2021
Waiver of WTO Protections for Big Pharma Will Help U.S. Economic Recovery and Boost U.S. Employment April 12, 2021
Waiver of the WTO’s Intellectual Property Rules: Existing TRIPS “Flexibilities” Unworkable for Necessary Scale Up of COVID-19 Medicines Production April 5, 2021